The $3.2 million expansion in downtown Indianapolis comes as the cloud-based sales platform company rebrands itself as Octiv.
The woman-owned digital marketing service provider will benefit from up to $2,825,000 in conditional tax credits and up to $100,000 in training grants.
Thanks to the software company's $40 million investment, 111 Monument Circle will be renamed Salesforce Tower Indianapolis.
The planned separation of DowDupont into three companies will create an Agriculture company corporate headquarters in Wilmington, DE with Global Business Centers in Indianapolis, IN and Johnston, IA.
Heartland Food Products Group, a producer and marketer of low calorie sweeteners, drink mixes, coffee and nutritional beverages, will expand its operations in Indianapolis, creating up to 187 new jobs by 2020.
Milhaus, a mixed-use development company, will expand its operations in Indianapolis, creating up to 250 new jobs by 2020.
Eli Lilly and Company will expand its global R&D headquarters in Indianapolis, IN, adding 130,000 square feet to the company's existing complex.
Rolls-Royce plans to invest nearly $600 million in its operations and research in Indianapolis over the next five years.
Raytheon announces facility expansion and 250 new jobs in Indianapolis.
When its Indianapolis facility reaches full production by the end of the year, it will operate more than 25 automatic and manual presses.
The Indianapolis order fulfillment center will enable Newegg to handle 30,000 different products and ship tens of thousands of orders daily to its Midwestern customers.
Despite economic and political turbulence, global commercial real estate investors will be more willing to take risks in 2014
Reflex & Allen, which has more than 500 employees globally, has already hired finance, sales, quality, operations, engineering, warehousing and production associates and will continue to recruit extrusion and general operators as part of this expansion.
AES, which currently has 25,000 associates globally, including 3,600 employees in the United States, will immediately begin filling new positions across the company.
As the global financial system continues to mend, venture capital is beginning to flow back into the biotechnology sector. In Europe, the largest biomed players are thriving, while entrepreneurial biotech start-ups gain traction in the U.S. From the March/April 2013 issue.
12Page 1 of 2